Cholinesterase inhibitors in Alzheimer's disease: donepezil or rivastigmine?

被引：0
|
作者：
Sharma, JC [1 ]
机构：
[1] Mansfield Community Hosp, Mansfield, Notts, England
来源：
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE | 2002年 / 56卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：414 / 415
页数：2
相关论文
共 50 条
  • [31] Cholinesterases in Alzheimer's disease and cholinesterase inhibitors in Alzheimer therapy
    Rakonczay, Z
    Kovács, I
    ACTA BIOLOGICA HUNGARICA, 1998, 49 (01): : 55 - 70
  • [32] Chromone and donepezil hybrids as new multipotent cholinesterase and monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease
    Wang, Xiao-Bing
    Yin, Fu-Cheng
    Huang, Ming
    Jiang, Neng
    Lan, Jin-Shuai
    Kong, Ling-Yi
    RSC MEDICINAL CHEMISTRY, 2020, 11 (02): : 225 - 233
  • [33] Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease
    Jann, MW
    PHARMACOTHERAPY, 2000, 20 (01): : 1 - 12
  • [34] The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease
    Loveman, E
    Green, C
    Kirby, J
    Takeda, A
    Picot, J
    Payne, E
    Clegg, A
    HEALTH TECHNOLOGY ASSESSMENT, 2006, 10 (01) : III - +
  • [35] Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease
    Blesa, Rafael
    Bullock, Roger
    He, Yunsheng
    Bergman, Howard
    Gambina, Giuseppe
    Meyer, Joanne
    Rapatz, Guenter
    Nagel, Jennifer
    Lane, Roger
    PHARMACOGENETICS AND GENOMICS, 2006, 16 (11): : 771 - 774
  • [36] Donepezil versus rivastigmine tolerability study in dementia with Lewy bodies and Alzheimer's disease
    Magierski, R.
    Sobow, T.
    Kloszewska, I.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S62 - S62
  • [37] Effectiveness of switching to the rivastigmine transdermal patch from oral cholinesterase inhibitors: a naturalistic prospective study in Alzheimer's disease
    Cagnin, Annachiara
    Cester, Alberto
    Costa, Bruno
    Ermani, Mario
    Gabelli, Carlo
    Gambina, Giuseppe
    NEUROLOGICAL SCIENCES, 2015, 36 (03) : 457 - 463
  • [38] Efficacy and Safety of Switching from Oral Cholinesterase Inhibitors to the Rivastigmine Transdermal Patch in Patients with Probable Alzheimer's Disease
    Han, Hyun Jeong
    Lee, Jeong Ju
    Park, Sun A.
    Park, Hyun Young
    Kim, Jeong Eun
    Shim, Young Soo
    Shim, Dong-Seok
    Kim, Eun-Joo
    Yoon, Soo Jin
    Choi, Seong Hye
    JOURNAL OF CLINICAL NEUROLOGY, 2011, 7 (03): : 137 - 142
  • [39] Effectiveness of switching to the rivastigmine transdermal patch from oral cholinesterase inhibitors: a naturalistic prospective study in Alzheimer’s disease
    Annachiara Cagnin
    Alberto Cester
    Bruno Costa
    Mario Ermani
    Carlo Gabelli
    Giuseppe Gambina
    Neurological Sciences, 2015, 36 : 457 - 463
  • [40] Cholinesterase inhibitors for Alzheimer disease
    Finucane, TE
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (18): : 2359 - 2359
12345